Celldex Therapeutics buy Wells Fargo & Company
Start price
15:02
/
50%
€28.40
Target price
27.09.25
-
Performance (%)
0.00%
Price
26.09.24
€32.40
Summary
This prediction is currently active. Wells_Fargo___Compan's BUY prediction for Celldex Therapeutics is currently unchanged. This prediction currently runs until 27.09.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Celldex Therapeutics | 0.00% |
| iShares Core DAX® | 1.518% |
| iShares Nasdaq 100 | 1.240% |
| iShares Nikkei 225® | 2.808% |
| iShares S&P 500 | 0.403% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) was upgraded by analysts at Wells Fargo & Company from a "hold" rating to a "strong-buy" rating.
Ratings data for CLDX provided by MarketBeat